The global Anti-inflammatory Therapeutics market size was valued at USD 113740 million in 2022 and is forecast to a readjusted size of USD 169200 million by 2029 with a CAGR of 5.8% during review period.
Anti-inflammatory therapeutics are treatments for arthritis, respiratory diseases, dermatology, psoriasis, inflammatory bowel disease and other inflammatory diseases. The treatments include anti-inflammatory biologics, NSAIDs, corticosteroids and others.
Top 5 manufacturers make up the major market share in the anti-inflammatory therapeutics market. AbbVie maintained its first place in the ranking in 2019, accounted for 21.59% market share. Other players accounted for 14.20%, 5.43%, 5.32% including Johnson & Johnson, Amgen Inc, AstraZeneca PLC.
This report is a detailed and comprehensive analysis for global Anti-inflammatory Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-inflammatory Therapeutics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Anti-inflammatory Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Anti-inflammatory Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Anti-inflammatory Therapeutics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-inflammatory Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-inflammatory Therapeutics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Merck
Sanofi
GlaxoSmithKline
Sun Pharmaceutical Industries Ltd
TEVA
Anti-inflammatory Biologics
Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Others
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Strengths
- Increasing prevalence of chronic inflammatory diseases globally is driving market demand for anti-inflammatory drugs.
- Ongoing advancements in biologics and personalized medicine are enhancing treatment efficacy and market growth.
Weaknesses
- High cost of novel biologic therapies may limit accessibility and adoption in low-income regions.
- Side effects associated with long-term use of anti-inflammatory drugs could deter patients from opting for these therapies.
Opportunities
- Expanding pipeline of novel anti-inflammatory drugs offers potential for market expansion and differentiation.
- Growing awareness and early diagnosis of inflammatory diseases present new market opportunities in emerging regions.
Threats
- Patent expirations of key anti-inflammatory drugs could lead to generic competition and revenue loss for major players.
- Regulatory challenges and pricing pressures in major markets could hinder the growth of anti-inflammatory therapeutics.
Political
- Government regulations regarding drug approvals and pricing policies could influence market dynamics for anti-inflammatory therapies.
- Political stability and healthcare policies in emerging markets are crucial for the growth and expansion of the market.
Economic
- Rising healthcare expenditure, especially in developed countries, is likely to support the growth of anti-inflammatory therapeutics.
- Economic downturns or budget cuts in healthcare systems could reduce funding for newer, expensive therapies.
Social
- Increasing awareness about chronic inflammatory diseases is driving demand for anti-inflammatory drugs, especially among aging populations.
- Lifestyle changes and dietary habits that contribute to inflammation could increase demand for preventive anti-inflammatory treatments.
Technological
- Advancements in biotechnology, such as monoclonal antibodies and gene therapies, are creating opportunities for more targeted and effective treatments.
- Increasing reliance on AI and digital technologies in drug discovery can accelerate the development of innovative anti-inflammatory therapies.
Environmental
- The environmental impact of pharmaceutical manufacturing and waste disposal is under growing scrutiny, potentially affecting production practices.
- Sustainability trends are pushing pharmaceutical companies to develop eco-friendly and green manufacturing processes.
Legal
- Intellectual property laws and patent expirations may influence market competition and availability of generic anti-inflammatory drugs.
- Stringent regulatory frameworks for drug safety and clinical trials could impact the time to market for new therapies.
Suppliers
- Biopharmaceutical companies, including major players and emerging biotech firms, provide raw materials and advanced technologies for developing anti-inflammatory drugs.
- Regulatory bodies like the FDA and EMA set guidelines for manufacturing standards, impacting the supply chain for therapeutics.
Inputs
- Active pharmaceutical ingredients (APIs), raw materials for drug formulation, and biotechnological tools for drug production are critical inputs in the process.
- Clinical research data and regulatory documentation are essential for drug development and approval.
Processes
- Drug discovery, clinical trials, and regulatory approval are the key processes for developing anti-inflammatory therapeutics.
- Manufacturing and distribution processes, including formulation and packaging, ensure the availability of finished products in the market.
Outputs
- Effective anti-inflammatory drugs, including both generic and branded therapeutics, are delivered to healthcare providers and patients.
- Ongoing research and development outputs include new drug formulations and improved treatment options for chronic inflammatory conditions.
Customers
- Healthcare providers, including doctors and hospitals, prescribe anti-inflammatory therapeutics to manage patient conditions.
- Patients, particularly those with chronic inflammatory diseases like rheumatoid arthritis and inflammatory bowel disease, are the end users of these therapies.
Threat of New Entrants
- High capital investment and regulatory hurdles make it challenging for new companies to enter the market.
- However, advancements in biotechnology and the rise of biosimilars may lower entry barriers for smaller biotech firms.
Bargaining Power of Suppliers
- Limited number of suppliers for specialized raw materials and active pharmaceutical ingredients increases supplier power.
- Dependence on regulatory bodies for approval processes can give suppliers significant influence over market dynamics.
Bargaining Power of Buyers
- Healthcare providers and patients have moderate bargaining power, driven by increased treatment options and competition.
- In developed markets, insurance companies’ negotiation power can affect pricing and access to anti-inflammatory drugs.
Threat of Substitute Products
- The threat of substitutes is moderate, with alternative treatments like physical therapy, dietary modifications, and natural remedies gaining popularity.
- However, prescription medications often offer more targeted and effective solutions for chronic inflammatory conditions.
Industry Rivalry
- Intense competition exists between established pharmaceutical companies, especially in biologics and biosimilars, which are pushing for market share.
- The race to develop novel, more effective anti-inflammatory therapies heightens competition and innovation in the market.
Raw Materials and Inputs
- The availability of high-quality active pharmaceutical ingredients (APIs) and biologic materials is essential for the production of anti-inflammatory therapeutics.
- Growing demand for complex biologics and monoclonal antibodies is driving the need for specialized suppliers and advanced manufacturing facilities.
Research and Development
- Investment in R&D is critical for developing new anti-inflammatory drugs, with significant focus on biologics and personalized medicine.
- Collaboration between pharmaceutical companies and academic institutions is accelerating innovation in anti-inflammatory treatments.
Regulatory and Compliance
- Regulatory approval processes, including clinical trials and safety evaluations, are significant upstream factors influencing the market dynamics.
- The cost and time involved in meeting regulatory requirements for new drug approvals are key challenges for upstream players in the industry.
Technology and Manufacturing Capabilities
- Advanced biotechnological tools and innovations in manufacturing, such as cell culture and gene therapies, are shaping the production of next-generation therapeutics.
- Automation and AI-driven technologies in drug discovery and manufacturing are improving efficiency and reducing costs in the upstream supply chain.
Manufacturing and Production
- The scaling up of biologic drug production, including monoclonal antibodies and other advanced therapies, is critical for meeting growing demand.
- Ensuring quality control and consistency in large-scale manufacturing processes remains a challenge, particularly for complex biologics.
Distribution and Supply Chain
- Efficient distribution networks, including partnerships with logistics firms, are essential for ensuring timely delivery of therapeutics to healthcare providers.
- Global supply chain disruptions and shortages of raw materials, especially during crises, could impact the availability of anti-inflammatory drugs.
Marketing and Sales
- Pharmaceutical companies are investing in targeted marketing strategies to promote their anti-inflammatory therapeutics, particularly in emerging markets.
- The increasing role of digital marketing and telemedicine is changing how anti-inflammatory drugs are marketed and prescribed.
Healthcare Provider Collaboration
- Collaboration with healthcare providers, such as rheumatologists and dermatologists, is vital for ensuring optimal drug use and market penetration.
- Building strong relationships with healthcare systems and insurance companies helps drive the adoption of new therapies.
End-Users and Patients
- The growing prevalence of chronic inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease increases demand for anti-inflammatory therapeutics among patients.
- The shift toward personalized medicine means more targeted therapies for individual patients, improving treatment outcomes and patient satisfaction.
Healthcare Providers and Prescription Trends
- Healthcare providers are increasingly focusing on precision medicine, prescribing biologics and tailored treatments based on patient-specific factors.
- The rising adoption of digital health tools and telemedicine has influenced prescription patterns, making remote consultations and drug management more common in the treatment of inflammatory conditions.
Insurance and Reimbursement
- Payers and insurance companies play a significant role in determining market access and affordability for expensive anti-inflammatory treatments.
- The growing emphasis on cost-effective therapies, including generics and biosimilars, is shifting reimbursement strategies in many regions, impacting the adoption of newer biologics.
Patient Support and Education
- Patient education programs are becoming more prominent in ensuring adherence to anti-inflammatory drug regimens and managing side effects effectively.
- Support programs from pharmaceutical companies are helping patients navigate insurance and access high-cost therapies, improving treatment outcomes.
Chapter 1, to describe Anti-inflammatory Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Anti-inflammatory Therapeutics, with revenue, gross margin and global market share of Anti-inflammatory Therapeutics from 2018 to 2023.
Chapter 3, the Anti-inflammatory Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Anti-inflammatory Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-inflammatory Therapeutics.
Chapter 13, to describe Anti-inflammatory Therapeutics research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Anti-inflammatory Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-inflammatory Therapeutics by Type
1.3.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Type in 2022
1.3.3 Anti-inflammatory Biologics
1.3.4 Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
1.3.5 Corticosteroids
1.3.6 Others
1.4 Global Anti-inflammatory Therapeutics Market by Application
1.4.1 Overview: Global Anti-inflammatory Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Arthritis
1.4.3 Respiratory Diseases
1.4.4 Dermatology
1.4.5 Gastroenterology
1.4.6 Others
1.5 Global Anti-inflammatory Therapeutics Market Size & Forecast
1.6 Global Anti-inflammatory Therapeutics Market Size and Forecast by Region
1.6.1 Global Anti-inflammatory Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Anti-inflammatory Therapeutics Market Size by Region, (2018-2029)
1.6.3 North America Anti-inflammatory Therapeutics Market Size and Prospect (2018-2029)
1.6.4 Europe Anti-inflammatory Therapeutics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Anti-inflammatory Therapeutics Market Size and Prospect (2018-2029)
1.6.6 South America Anti-inflammatory Therapeutics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Anti-inflammatory Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 AbbVie
2.1.1 AbbVie Details
2.1.2 AbbVie Major Business
2.1.3 AbbVie Anti-inflammatory Therapeutics Product and Solutions
2.1.4 AbbVie Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 AbbVie Recent Developments and Future Plans
2.2 Johnson & Johnson
2.2.1 Johnson & Johnson Details
2.2.2 Johnson & Johnson Major Business
2.2.3 Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
2.2.4 Johnson & Johnson Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Johnson & Johnson Recent Developments and Future Plans
2.3 Amgen Inc
2.3.1 Amgen Inc Details
2.3.2 Amgen Inc Major Business
2.3.3 Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
2.3.4 Amgen Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Amgen Inc Recent Developments and Future Plans
2.4 AstraZeneca PLC
2.4.1 AstraZeneca PLC Details
2.4.2 AstraZeneca PLC Major Business
2.4.3 AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
2.4.4 AstraZeneca PLC Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AstraZeneca PLC Recent Developments and Future Plans
2.5 Pfizer, Inc
2.5.1 Pfizer, Inc Details
2.5.2 Pfizer, Inc Major Business
2.5.3 Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
2.5.4 Pfizer, Inc Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Pfizer, Inc Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Anti-inflammatory Therapeutics Product and Solutions
2.6.4 Novartis Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Anti-inflammatory Therapeutics Product and Solutions
2.7.4 Roche Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Roche Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Anti-inflammatory Therapeutics Product and Solutions
2.8.4 Merck Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Merck Recent Developments and Future Plans
2.9 Sanofi
2.9.1 Sanofi Details
2.9.2 Sanofi Major Business
2.9.3 Sanofi Anti-inflammatory Therapeutics Product and Solutions
2.9.4 Sanofi Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Sanofi Recent Developments and Future Plans
2.10 GlaxoSmithKline
2.10.1 GlaxoSmithKline Details
2.10.2 GlaxoSmithKline Major Business
2.10.3 GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
2.10.4 GlaxoSmithKline Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GlaxoSmithKline Recent Developments and Future Plans
2.11 Sun Pharmaceutical Industries Ltd
2.11.1 Sun Pharmaceutical Industries Ltd Details
2.11.2 Sun Pharmaceutical Industries Ltd Major Business
2.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
2.11.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
2.12 TEVA
2.12.1 TEVA Details
2.12.2 TEVA Major Business
2.12.3 TEVA Anti-inflammatory Therapeutics Product and Solutions
2.12.4 TEVA Anti-inflammatory Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 TEVA Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Anti-inflammatory Therapeutics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Anti-inflammatory Therapeutics by Company Revenue
3.2.2 Top 3 Anti-inflammatory Therapeutics Players Market Share in 2022
3.2.3 Top 6 Anti-inflammatory Therapeutics Players Market Share in 2022
3.3 Anti-inflammatory Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Anti-inflammatory Therapeutics Market: Region Footprint
3.3.2 Anti-inflammatory Therapeutics Market: Company Product Type Footprint
3.3.3 Anti-inflammatory Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Anti-inflammatory Therapeutics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Anti-inflammatory Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2018-2023)
5.2 Global Anti-inflammatory Therapeutics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Anti-inflammatory Therapeutics Consumption Value by Type (2018-2029)
6.2 North America Anti-inflammatory Therapeutics Consumption Value by Application (2018-2029)
6.3 North America Anti-inflammatory Therapeutics Market Size by Country
6.3.1 North America Anti-inflammatory Therapeutics Consumption Value by Country (2018-2029)
6.3.2 United States Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
6.3.3 Canada Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
6.3.4 Mexico Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Anti-inflammatory Therapeutics Consumption Value by Type (2018-2029)
7.2 Europe Anti-inflammatory Therapeutics Consumption Value by Application (2018-2029)
7.3 Europe Anti-inflammatory Therapeutics Market Size by Country
7.3.1 Europe Anti-inflammatory Therapeutics Consumption Value by Country (2018-2029)
7.3.2 Germany Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
7.3.3 France Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
7.3.5 Russia Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
7.3.6 Italy Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Anti-inflammatory Therapeutics Market Size by Region
8.3.1 Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2018-2029)
8.3.2 China Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
8.3.3 Japan Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
8.3.4 South Korea Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
8.3.5 India Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
8.3.7 Australia Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Anti-inflammatory Therapeutics Consumption Value by Type (2018-2029)
9.2 South America Anti-inflammatory Therapeutics Consumption Value by Application (2018-2029)
9.3 South America Anti-inflammatory Therapeutics Market Size by Country
9.3.1 South America Anti-inflammatory Therapeutics Consumption Value by Country (2018-2029)
9.3.2 Brazil Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
9.3.3 Argentina Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Anti-inflammatory Therapeutics Market Size by Country
10.3.1 Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2018-2029)
10.3.2 Turkey Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
10.3.4 UAE Anti-inflammatory Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Anti-inflammatory Therapeutics Market Drivers
11.2 Anti-inflammatory Therapeutics Market Restraints
11.3 Anti-inflammatory Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Anti-inflammatory Therapeutics Industry Chain
12.2 Anti-inflammatory Therapeutics Upstream Analysis
12.3 Anti-inflammatory Therapeutics Midstream Analysis
12.4 Anti-inflammatory Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Anti-inflammatory Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-inflammatory Therapeutics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Anti-inflammatory Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Anti-inflammatory Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. AbbVie Company Information, Head Office, and Major Competitors
Table 6. AbbVie Major Business
Table 7. AbbVie Anti-inflammatory Therapeutics Product and Solutions
Table 8. AbbVie Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. AbbVie Recent Developments and Future Plans
Table 10. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 11. Johnson & Johnson Major Business
Table 12. Johnson & Johnson Anti-inflammatory Therapeutics Product and Solutions
Table 13. Johnson & Johnson Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Johnson & Johnson Recent Developments and Future Plans
Table 15. Amgen Inc Company Information, Head Office, and Major Competitors
Table 16. Amgen Inc Major Business
Table 17. Amgen Inc Anti-inflammatory Therapeutics Product and Solutions
Table 18. Amgen Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Amgen Inc Recent Developments and Future Plans
Table 20. AstraZeneca PLC Company Information, Head Office, and Major Competitors
Table 21. AstraZeneca PLC Major Business
Table 22. AstraZeneca PLC Anti-inflammatory Therapeutics Product and Solutions
Table 23. AstraZeneca PLC Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. AstraZeneca PLC Recent Developments and Future Plans
Table 25. Pfizer, Inc Company Information, Head Office, and Major Competitors
Table 26. Pfizer, Inc Major Business
Table 27. Pfizer, Inc Anti-inflammatory Therapeutics Product and Solutions
Table 28. Pfizer, Inc Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Pfizer, Inc Recent Developments and Future Plans
Table 30. Novartis Company Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Anti-inflammatory Therapeutics Product and Solutions
Table 33. Novartis Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Novartis Recent Developments and Future Plans
Table 35. Roche Company Information, Head Office, and Major Competitors
Table 36. Roche Major Business
Table 37. Roche Anti-inflammatory Therapeutics Product and Solutions
Table 38. Roche Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Roche Recent Developments and Future Plans
Table 40. Merck Company Information, Head Office, and Major Competitors
Table 41. Merck Major Business
Table 42. Merck Anti-inflammatory Therapeutics Product and Solutions
Table 43. Merck Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Merck Recent Developments and Future Plans
Table 45. Sanofi Company Information, Head Office, and Major Competitors
Table 46. Sanofi Major Business
Table 47. Sanofi Anti-inflammatory Therapeutics Product and Solutions
Table 48. Sanofi Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Sanofi Recent Developments and Future Plans
Table 50. GlaxoSmithKline Company Information, Head Office, and Major Competitors
Table 51. GlaxoSmithKline Major Business
Table 52. GlaxoSmithKline Anti-inflammatory Therapeutics Product and Solutions
Table 53. GlaxoSmithKline Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. GlaxoSmithKline Recent Developments and Future Plans
Table 55. Sun Pharmaceutical Industries Ltd Company Information, Head Office, and Major Competitors
Table 56. Sun Pharmaceutical Industries Ltd Major Business
Table 57. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Product and Solutions
Table 58. Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Sun Pharmaceutical Industries Ltd Recent Developments and Future Plans
Table 60. TEVA Company Information, Head Office, and Major Competitors
Table 61. TEVA Major Business
Table 62. TEVA Anti-inflammatory Therapeutics Product and Solutions
Table 63. TEVA Anti-inflammatory Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. TEVA Recent Developments and Future Plans
Table 65. Global Anti-inflammatory Therapeutics Revenue (USD Million) by Players (2018-2023)
Table 66. Global Anti-inflammatory Therapeutics Revenue Share by Players (2018-2023)
Table 67. Breakdown of Anti-inflammatory Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Anti-inflammatory Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Anti-inflammatory Therapeutics Players
Table 70. Anti-inflammatory Therapeutics Market: Company Product Type Footprint
Table 71. Anti-inflammatory Therapeutics Market: Company Product Application Footprint
Table 72. Anti-inflammatory Therapeutics New Market Entrants and Barriers to Market Entry
Table 73. Anti-inflammatory Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Anti-inflammatory Therapeutics Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Anti-inflammatory Therapeutics Consumption Value Share by Type (2018-2023)
Table 76. Global Anti-inflammatory Therapeutics Consumption Value Forecast by Type (2024-2029)
Table 77. Global Anti-inflammatory Therapeutics Consumption Value by Application (2018-2023)
Table 78. Global Anti-inflammatory Therapeutics Consumption Value Forecast by Application (2024-2029)
Table 79. North America Anti-inflammatory Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Anti-inflammatory Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Anti-inflammatory Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Anti-inflammatory Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Anti-inflammatory Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Anti-inflammatory Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Anti-inflammatory Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Anti-inflammatory Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Anti-inflammatory Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Anti-inflammatory Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Anti-inflammatory Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Anti-inflammatory Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Anti-inflammatory Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Anti-inflammatory Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Anti-inflammatory Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Anti-inflammatory Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Anti-inflammatory Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Anti-inflammatory Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Anti-inflammatory Therapeutics Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Anti-inflammatory Therapeutics Raw Material
Table 110. Key Suppliers of Anti-inflammatory Therapeutics Raw Materials
List of Figures
Figure 1. Anti-inflammatory Therapeutics Picture
Figure 2. Global Anti-inflammatory Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Type in 2022
Figure 4. Anti-inflammatory Biologics
Figure 5. Non-Steroidal Anti-inflammatory Drugs (NSAIDs)
Figure 6. Corticosteroids
Figure 7. Others
Figure 8. Global Anti-inflammatory Therapeutics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Anti-inflammatory Therapeutics Consumption Value Market Share by Application in 2022
Figure 10. Arthritis Picture
Figure 11. Respiratory Diseases Picture
Figure 12. Dermatology Picture
Figure 13. Gastroenterology Picture
Figure 14. Others Picture
Figure 15. Global Anti-inflammatory Therapeutics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Anti-inflammatory Therapeutics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Anti-inflammatory Therapeutics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Anti-inflammatory Therapeutics Consumption Value Market Share by Region in 2022
Figure 20. North America Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Anti-inflammatory Therapeutics Revenue Share by Players in 2022
Figure 26. Anti-inflammatory Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Anti-inflammatory Therapeutics Market Share in 2022
Figure 28. Global Top 6 Players Anti-inflammatory Therapeutics Market Share in 2022
Figure 29. Global Anti-inflammatory Therapeutics Consumption Value Share by Type (2018-2023)
Figure 30. Global Anti-inflammatory Therapeutics Market Share Forecast by Type (2024-2029)
Figure 31. Global Anti-inflammatory Therapeutics Consumption Value Share by Application (2018-2023)
Figure 32. Global Anti-inflammatory Therapeutics Market Share Forecast by Application (2024-2029)
Figure 33. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 43. France Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Anti-inflammatory Therapeutics Consumption Value Market Share by Region (2018-2029)
Figure 50. China Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 53. India Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Anti-inflammatory Therapeutics Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Anti-inflammatory Therapeutics Consumption Value (2018-2029) & (USD Million)
Figure 67. Anti-inflammatory Therapeutics Market Drivers
Figure 68. Anti-inflammatory Therapeutics Market Restraints
Figure 69. Anti-inflammatory Therapeutics Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Anti-inflammatory Therapeutics in 2022
Figure 72. Manufacturing Process Analysis of Anti-inflammatory Therapeutics
Figure 73. Anti-inflammatory Therapeutics Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
